This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Emendobio Inc.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Idit Buch: Innovator in CRISPR Technology
Introduction
Idit Buch is a prominent inventor based in Hod-Hasharon, Israel. She has made significant contributions to the field of genetic engineering, particularly through her work with CRISPR technology. Her innovative approach has led to the development of a unique patent that showcases her expertise and dedication to advancing scientific research.
Latest Patents
Idit Buch holds a patent for OMNI-103 CRISPR nuclease. This invention provides a non-naturally occurring composition comprising a CRISPR nuclease that includes a sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 1 or a nucleic acid molecule that encodes the CRISPR nuclease. This groundbreaking work has the potential to revolutionize genetic editing and therapeutic applications.
Career Highlights
Throughout her career, Idit has demonstrated a strong commitment to innovation and research. She is currently associated with Emendo Bio Inc., a company focused on developing advanced genetic engineering solutions. Her work at Emendo Bio Inc. reflects her dedication to pushing the boundaries of what is possible in the field of biotechnology.
Collaborations
Idit Buch collaborates with talented individuals such as Lior Izhar and Nadav Marbach Bar. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Idit Buch is a remarkable inventor whose work in CRISPR technology is paving the way for future advancements in genetic engineering. Her contributions are not only significant but also essential for the ongoing evolution of biotechnology.